Back to today’s briefing

Story perspectives

FDA Approves HIV Prevention Amid Budget Cuts Crisis

7/3/2025

39 4

Summary

Story summary

Mitchell Warren underscores the stark irony in the FDA's approval of lenacapavir for HIV prevention, as U.S. budget cuts to USAID and PEPFAR threaten its implementation. Despite global leaders' pledges, the rollout is fraught with obstacles, putting at risk the goal of swiftly reaching two million individuals, even as scientific breakthroughs offer hope.

1 of 1

Story summary

Mitchell Warren underscores the stark irony in the FDA's approval of lenacapavir for HIV prevention, as U.S. budget cuts to USAID and PEPFAR threaten its implementation. Despite global leaders' pledges, the rollout is fraught with obstacles, putting at risk the goal of swiftly reaching two million individuals, even as scientific breakthroughs offer hope.